Protein Z/protein Z-dependent protease inhibitor system in human non-small-cell lung cancer tissue

Thrombosis Research

Volumn 129, Issue 4, 2012, Pages

  Sierko, Ewa ^a,b   Wojtukiewicz, Marek Z ^a,b   Zimnoch, Lech ^a   Ostrowska Cichocka, Krystyna ^b   Tokajuk, Piotr ^b   Ramlau, Rodryg ^c   Kisiel, Walter ^d  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Regional Comprehensive Cancer Center in Bialystok   (Poland)

^c Greatpoland Pulmonary Diseases and Tuberculosis Center   (Poland)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

coagulation inhibitor; factor IX; factor X; non small cell lung cancer; protein Z; protein Z dependent protease inhibitor

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 9; FATTY ACID BINDING PROTEIN; FIBRIN; PROTEIN Z DEPENDENT PROTEASE INHIBITOR; PROTEINASE INHIBITOR; PROTHROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER TISSUE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; TUMOR ASSOCIATED LEUKOCYTE;

BLOOD COAGULATION FACTORS; BLOOD PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; SERPINS; TUMOR CELLS, CULTURED;

EID: 84858336525     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.09.005     Document Type: Article

References (37)

1. R.L. Bick Coagulation abnormalities in malignancy: a review Semin Thromb Hemost 18 1992 353 372
2. A. Falanga, and F.R. Rickles Patophysiology of the thrombophilic state in the cancer patient Semin Thromb Hemost 25 1999 173 182
3. L.R. Zacharski, M.Z. Wojtukiewicz, V. Costantini, D.L. Ornstein, and V.A. Memoli Pathways of coagulation/fibrinolysis activation in malignancy Semin Thromb Hemost 18 1992 104 116
4. M.Z. Wojtukiewicz, L.R. Zacharski, T.E. Moritz, K. Hur, R.I. Edwards, and F.R. Rickles Prognostic significance of blood coagulation tests in carcinoma of the lung and colon Blood Coagul Fibrinolysis 3 1992 429 437
5. G. Buccheri, D. Ferrigno, C. Ginardi, and C. Zuliani Haemostatic abnormalities in lung cancer: prognostic implications Eur J Cancer 33 1998 50 55
6. R. Seitz, H.H. Heidtmann, M. Wolf, A. Immel, and R. Egbring Prognostic impact of an activation of coagulation in lung cancer Ann Oncol 9 1997 1255 1256
7. H.T. Sorensen, L. Mellemkjaer, J.H. Olson, and G.L. Nielsen Prognosis of cancers associated with venous thromboembolism N Eng J Med 343 2000 1846 1850
8. L.V.M. Rao Tissue factor as a tumor procoagulant Cancer Metastasis Rev 11 1992 249 266
9. M.Z. Wojtukiewicz, E. Sierko, and J. Rak Contribution of hemostatic system to angiogenesis in cancer Semin Thromb Hemost 30 2004 5 20
10. M.Z. Wojtukiewicz, E. Sierko, and W. Kisiel The role of hemostatic system inhibitors in malignancy Semin Thromb Hemost 33 2007 621 641
11. G.J. Broze Jr., and J.P. Miletich Human protein Z J Clin Invest 73 1984 933 938
12. X. Han, Z.F. Huang, R. Fiehler, and G.J. Broze Jr. The protein Z-dependent protease inhibitor is a serpin Biochemistry 38 1999 11073 11078
13. X. Han, R. Fiehler, and G.J. Broze Jr. Characterization of protein Z-dependent protease inhibitor Blood 96 2000 3049 3055
14. A. Tabatabai, R. Fiehler, and G.J. Broze Jr. Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor Thromb Haemost 85 2001 655 660
15. G.J. Broze Jr. Protein Z-dependent regulation of coagulation Thromb Haemost 86 2001 8 13
16. X. Huang, A.R. Rezaire, G.J. Broze Jr., and S.T. Olsen Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor J Biol Chem 286 2011 8740 8751
17. A.R. Rezaie, C. Manithody, and L. Yang Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor J Biol Chem 280 2005 32722 32728
18. A.R. Rezaie, J.-S. Bae, C. Manithody, S.H. Qureshi, and L. Yang Protein Z - dependent protease inhibitor binds to the C-terminal domain of protein Z J Biol Chem 283 2008 19922 19926
19. M.J. Heeb, K.M. Cabral, and L. Ruan Down-regulation of factor IXa in the factor Xase complex by protein Z-dependent protease inhibitor J Biol Chem 280 2005 33819 33825
20. M.Z. Wojtukiewicz, M. Rucińska, L. Zimnoch, J. Jaromin, Z. Piotrowski, M. Rózańska-Kudelska, W. Kisiel, and B.J. Kudryk Expression of prothrombin fragment 1+2 in cancer tissue as an indicator of local activation of blood coagulation Thromb Res 97 2000 335 342
21. S. Hsu, L. Raine, and H. Fanger Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures J Histochem Cytochem 29 1981 577 580
22. E. Sierko, M.Z. Wojtukiewicz, K. Ostrowska-Cichocka, and L. Zimnoch Protein Z-dependent protease inhibitor (ZPI) is present in loco in human breast cancer tissue Thromb Haemost 104 2010 183 185
23. E. Sierko, M.Z. Wojtukiewicz, L. Zimnoch, P. Tokajuk, and W. Kisiel Protein Z is present in human breast cancer tissue Int J Hematol 93 2011 681 683
24. M.Z. Wojtukiewicz, E. Sierko, L.R. Zacharski, L. Zimnoch, B. Kudryk, and W. Kisiel Tissue factor dependent coagulation activation and impaired fibrinolysis in loco in gastric cancer Semin Thromb Hemost 29 2003 291 299
25. B. Kudryk, A. Rohoza, M. Ahadi, J. Chin, and M.E. Wiebe Monoclonal antibodies with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin Mol Immunol 20 1983 1191 1200
26. B. Kudryk Specificity of a monoclonal antibody for NH2-terminal region of fibrin Mol Immunol 21 1984 89 94
27. E. Sierko, M.Z. Wojtukiewicz, L. Zimnoch, and W. Kisiel Tissue factor pathway inhibitor in breast and colon cancer tissue Thromb Haemost 103 2010 198 204
28. M.Z. Wojtukiewicz, T.G. Tang, E. Ben-Josef, C. Renaud, D.A. Walz, and K.V. Honn Solid tumor cells express functional "tethered ligand" thrombin receptor Cancer Res 55 1995 698 704
29. M.Z. Wojtukiewicz, T.G. Tang, J.J. Ciarelli, K.K. Nelson, D.A. Walz, C.A. Diglio, E.F. Mammen, and K.V. Honn Thrombin increases the metastatic potential of tumor cell Int J Cancer 54 1993 793 806
30. M.Z. Wojtukiewicz, T.G. Tang, K.K. Nelson, D.A. Walz, C.A. Diglio, and K.V. Honn Thrombin enhances tumor cell adhesive and metastatic properties via increased αIIbβ3 expression on the cell surface Thromb Res 68 1992 233 245
31. N.E. Tsopanoglou, and M.E. Maragoudakis On the mechanism of thrombin-induced angiogenesis J Biol Chem 274 1999 23969 23976
32. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other diseases Nat Med 1 1995 27 31
33. Y. Shang, X.Y. Pan, C.P. Ding, X.M. Yang, X.Y. Cai, and Y. Ding Clinical significance of protein Z detection in patients with malignant tumors Ai Zheng 24 2005 1144 1147
34. A. Amirkhosravi, T. Meyer, M. Amaya, M. Davila, S.A. Mousa, T. Robson, and J.L. Francis The Role of Tissue Factor Pathway Inhibitor in Tumor Growth and Metastasis Semin Thromb Hemost 33 2007 643 652
35. E. Sierko, M.Z. Wojtukiewicz, and W. Kisiel The role of tissue factor pathway inhibitor-2 in cancer biology Semin Thromb Hemost 33 2007 653 660
36. J. Greten, I. Kreis, B. Liliensiek, J. Amiral, R. Ziegler, and P.P. Nawroth Localization of protein Z in vascular lesions of patients with atherosclerosis Vasa 27 1998 144 148
37. D.L. Ornstein, L.R. Zacharski, V.A. Memoli, W. Kisiel, B.J. Kudryk, J. Hunt, S.M. Rousseau, and D.C. Stump Coexisting macrophage - associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues Cancer 68 1990 1061 1067